Carbidopa, Levodopa And Entacapone
Product Images NDC 55648-783

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 55648-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Lectaborion M Figure 01)

Structure (Lectaborion M Figure 01)
Chemical structure of carbidopa, levodopa and entacapone active ingredient. The diagram shows the molecular arrangement including functional groups and bonds, along with a water molecule (H2O) associated.*
FDA Label Image

Structure (Lectaborion M Figure 02)

Structure (Lectaborion M Figure 02)
Chemical structure of the active ingredient shown, depicting a molecule with a benzene ring substituted with two hydroxyl groups and a side chain including an amine and carboxylic acid group. This likely represents one of the active components related to carbidopa, levodopa, and entacapone products by Wockhardt Limited.*
FDA Label Image

Structure (Lectaborion M Figure 03)

Structure (Lectaborion M Figure 03)
Chemical structure diagram of the active ingredient, carbidopa, levodopa and entacapone, showing the arrangement of atoms and bonds in the molecule related to the product by Wockhardt Limited.*
FDA Label Image

Label (Lectaborion M Figure 04)

Label (Lectaborion M Figure 04)
Label for carbidopa, levodopa and entacapone tablets by Wockhardt Limited. The label states each film-coated tablet contains carbidopa 18.75 mg, levodopa 75 mg, and entacapone 200 mg. The package contains 100 tablets. Storage and handling instructions, manufacturer and distributor information, and a barcode are also visible.*
FDA Label Image

Label (Lectaborion M Figure 05)

Label (Lectaborion M Figure 05)
Label for Carbidopa, Levodopa and Entacapone Tablets, containing 31.25 mg carbidopa USP, 125 mg levodopa USP, and 200 mg entacapone per film-coated tablet. The package contains 100 tablets. Distributed by Wockhardt USA LLC and manufactured by Orion Corporation. Includes storage instructions and a barcode.*
FDA Label Image

Label (Lectaborion M Figure 06)

Label (Lectaborion M Figure 06)
Label for Carbidopa, Levodopa And Entacapone Tablets, each film-coated tablet containing 50 mg Carbidopa USP, 200 mg Levodopa USP, and 200 mg Entacapone. The label indicates a 100 tablet count and is distributed by Wockhardt USA LLC, with manufacturing by Orion Corporation in Finland. Storage instructions and caution about dosage are included, along with a barcode and RX only notice.*
FDA Label Image

Label (Lectaborion M Figure 07)

Label (Lectaborion M Figure 07)
Label for Carbidopa, Levodopa And Entacapone Tablets containing 100 tablets per bottle. Each film-coated tablet includes 12.5 mg Carbidopa USP, 50 mg Levodopa USP, and 200 mg Entacapone. Manufactured by Orion Corporation, Finland, and distributed by Wockhardt USA LLC, Parsippany, NJ. Storage instructions and dosage warnings are also present.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.